Key facts
- This page summarizes Michael S. Weiss's Form 4 filing for Fortress Biotech, Inc. (FBIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2026, 16:05.
Michael S. Weiss - 18 Mar 2026 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)
- Reporting relationship
- Executive Vice Chairman, Director
- Issuer ticker
- FBIO
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Mar 2026, 16:05:10 UTC
- Prior SEC filing
- 09 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Samuel Berry, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael S. Weiss filed Form 4 for Fortress Biotech, Inc. (FBIO) on 20 Mar 2026.
Change
- Previous filing in this sequence was filed on 09 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001038977
Primary reporting owner
WEISS MICHAEL S
- Relationship
- Executive Vice Chairman, Director
- Address
- C/O FORTRESS BIOTECH, INC., 1111 KANE CONCOURSE SUITE 301, BAY HARBOR ISLANDS
- Signature
- /s/ Samuel Berry, Attorney-in-Fact
- Signature date
- 20 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FBIO
transaction
common stock, par value $0.001
Award
- Transaction value
- Shares
- +475,424
- Change %
- +26%
- Price
- $0.000000*
- Shares after
- 2,276,562
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026.